ABSTRACT: Background. We recently described the imaging characteristics of multiple confluent regional metastases (matted nodes) and found that this characteristic was associated with distant metastasis in patients with oropharyngeal squamous cell carcinoma (SCC). The purpose of this study was to determine if matted nodes are a predictive marker for distant metastasis. Results. The 3-year disease-specific survival (DSS) for patients with matted nodes was 58% versus 97% with nonmatted nodes (p 5 .0001). The prevalence of matted nodes in the population was 20%. The positive predictive value of matted nodes for distant metastasis was 66%, and the negative predictive value was 99%. Conclusion. Matted nodes are a predictive marker for distant disease and can be used for planning new clinical interventions.
INTRODUCTION
Treatment failure from distant metastasis in patients with oropharyngeal squamous cell carcinoma (SCC) has doubled over the past 20 years and now accounts for approximately 45% of deaths. 1, 2 Several factors account for the increased prevalence of distant metastasis as the site of first failure in oropharyngeal SCC. First, excellent locoregional control rates have shifted the pattern of failure toward distant metastasis. 2 Second, the proportion of patients who die of other causes is lower because the cohort presenting with oropharyngeal SCC are younger, healthier, and have a lower incidence of tobacco use. This decreases the deaths from other causes and increases the relative proportion of patients who may go on to develop distant metastasis. In addition, human papillomavirus (HPV)-associated tumors may have altered the patterns of relapse with an increased rate of distant metastasis. [3] [4] [5] With the current interest in deescalating treatment of patients with oropharyngeal SCC, it would be beneficial to identify those patients at risk for distant disease so that they could be excluded from deescalation trials and alternative treatments could be evaluated. There has been previous work that has evaluated prognostic markers of distant metastasis. For example, preferential expression of micro-RNAs, 6 combination of advanced T and N classification, 7 and active smoking status 8 have all been evaluated as prognostic markers. The ideal way to identify patients at risk for distant metastasis would be predictive in nature, so that patients could be identified in a pretreatment fashion to help develop interventions to prevent treatment failure. Our previous work has identified matted nodes (defined as 3 nodes abutting one another with loss of intervening fat plane that is replaced with radiologic evidence of extracapsular spread [ECS]) as a prognostic marker for patients with oropharyngeal SCC, but the predictive value is unknown. 5 The purpose of this study was to define the predictive value of matted nodes for distant metastasis and survival in patients with oropharyngeal SCC. 
PATIENTS AND METHODS

Study population
All patients were treated under a uniform clinical protocol consisting of weekly concomitant carboplatin, paclitaxel, and intensity-modulated radiation therapy (IMRT) for advanced stage (III and IV) oropharyngeal SCC between 2003 and 2010. Staging was performed in accordance with the 2010 American Joint Committee on Cancer (AJCC) staging system with clinical examination, direct laryngoscopy in the operating room, and CT scan and/or CT/positron emission tomography scan. Patients were excluded if they had previous surgery or radiation therapy to the upper aerodigestive tract or if neck imaging was not performed within 4 weeks of the initiation of treatment.
Population characteristics
There were 215 patients who were treated with this regimen. Ten patients were excluded from this study because pretreatment imaging was unavailable for review or they had excisional lymph node biopsies before referral and definitive CT scan. Two hundred five previously untreated patients were identified and baseline characteristics are shown in 
Treatment protocol
Radiation therapy was delivered using daily fractionated IMRT, 5 days per week over 35 fractions. Prescription doses were 70 Gy at 2.0 Gy per fraction to gross disease and 59 to 63 Gy at 1.7 to 1.8 Gy per fraction to low-risk and high-risk subclinical regions, respectively, delivered concomitantly according to published methods. 9, 10 Chemotherapy consisted of weekly carboplatin (area under the curve 1) intravenous over 30 minutes and paclitaxel (30 mg/m 2 ) intravenous over 1 hour. Hydration and antiemetics were administered according to the standard of care.
Tissue microarray and immunostaining
A tissue microarray was constructed from pretreatment biopsies of the primary tumor for 176 of the 205 patients. Of the remaining patients, 10 had sufficient tissue to obtain a single slide from the paraffin-embedded biopsy and 19 did not have adequate tissue samples available for analysis. The tissue microarray and single slides were processed by a previously described method. 11 Staining for p16 was performed per protocol supplied by the kit (CINtec p16INK4a Histology Kit; mtm Laboratories, Westborough, MA). Antibody binding was scored by a pathologist (J.B.M.), using a continuous scale (ie, 10%, 30%, 90%, etc.) for the proportion of p16-positive tumor cells in each core or slide and the percentage scored was broken down into a ordinal scale of 1 to 4: 1 was <5%; 2 was 5% to 20%; 3 was 21% to 50%; and 4 was 51% to 100% tumor staining. Intensity was scored as 1 5 staining; 2 5 low intensity; 3 5 moderate; and 4 5 high intensity. Scores for multiple cores from each patient were averaged. Staining for p16 was considered positive when >75% of tumor cells demonstrated strong nuclear and cytoplasmic staining or >2 intensity.
Isolation of DNA from separately cored tissue samples was performed using the QIAamp DNA FFPE Tissue Kit (Qiagen, Valencia, CA). DNA concentration and purity were confirmed via NanoDrop spectrophotometer (Thermo Scientific, Waltham, MA). HPV status was determined by an ultrasensitive method using real-time competitive polymerase chain reaction (PCR) and matrix-assisted laser desorption/ ionization-time-of-flight mass spectroscopy with separation of products on a matrix-loaded silicon chip array. 12 HPV status was considered positive if either p16 staining was positive or PCR assay was positive. Table 2 shows the discordances between p16 staining and PCR assay results. The HPV status was known for 186 of 205 patients and was positive in 92% of cases. The pathologist was blinded to the clinical outcome.
Pretreatment imaging
Pretreatment CT or CT/positron emission tomography scans within 4 weeks of starting therapy were reviewed by a neuroradiologist (M.I.). Primary tumor site and size, distance of the primary tumor from the midline, and encasement of the carotid artery by the primary tumor were recorded. The size (largest 2 dimensions) and distribution (levels I-V) of each lymph node was recorded for each level of the neck. AJCC N3 disease was defined clinically as a lymph node or group of lymph nodes >6 centimeters. Matted nodes were defined as 3 nodes abutting one another with loss of intervening fat plane that is replaced with radiologic evidence of ECS ( Figure 1 ). ECS was defined with imaging as loss of the sharp plane between the capsule of the lymph node and the surrounding fat.
Statistical analysis
Outcomes of interest were overall survival (OS), disease-specific survival (DSS), and pattern of recurrence (local, regional, or distant). Survival estimates were defined from the date of diagnosis and were computed using the Kaplan-Meier method. Bivariate associations between matted nodes and other clinical variables were tested with exact tests (ie, Fisher's exact test, chi-square test with Monte Carlo estimates for error terms). The logrank test was used to evaluate univariate associations of survival and Cox models were used to evaluate the multivariate association of matted nodes with survival after controlling for clinical variables including age, T classification, tobacco status, and HPV status. This research was approved by the Institutional Review Board for human experimentation of the University of Michigan.
RESULTS
The purpose of this study was to ascertain the predictive value of matted nodes. The prevalence of matted nodes in the study population was 20%. There were 42 patients identified with matted nodes, with 28 (67%) of these patients developing distant metastasis. Of the 30 patients in the cohort who developed distant metastasis, 28 (93%) had matted nodes. The positive predictive value of developing distant metastasis when matted nodes are present was 66%, and the negative predictive value was 99%. The sensitivity and specificity of matted nodes to predict distant metastasis was 93 and 92%, respectively.
The 3-year OS was 83% and DSS was 88% for the cohort with a median follow-up 43 months. The 3-year DSS for patients with matted nodes was 58% and for patients with no evidence of matted nodes was 97% (Figure 2 ; p 5 .0001).
There were 186 patients who had HPV status determined and available for analysis. Of the 186 patients, there were 171 who were HPV positive. With univariate analyses, HPV-positive patients experienced a significantly improved DSS (3 year: 88% vs 69%; p 5 .05) and OS (3 year: 86% vs 60%; p 5 .02) when compared with HPV-negative patients (Figure 3) . There was no significant correlation of HPV status to the finding of matted nodes (p 5 .1; this is a strong trend, however, particularly with such a small number of HPV-negative patients). Although there were only 15 HPV-negative patients, this suggests that the predictive value of matted nodes is independent of HPV status.
With univariate analyses, there was no significant difference in DSS when stratifying by tobacco use ( Figure  4 ; p 5 .69). There were 61 never tobacco users, 72 prior tobacco users, and 72 current tobacco users. The 3-year DSS was 90%, 85%, and 88% in the never, prior, and current tobacco use groups, respectively. The correlation between matted nodes to tobacco status was not statistically significant (p > .2).
The prevalence of radiologic ECS in our cohort was 63% (129 of 205), consistent with our previous work. Patients with matted nodes, as we have previously defined, have ECS, and 42.4% (87 of 205) of the entire cohort had ECS without evidence of matted nodes. Figure  5 shows the OS and DSS of patients without ECS (blue curve), ECS with nonmatted nodes (green curve), and ECS with matted nodes (tan curve). There was no difference in OS or DSS in patients without ECS and patients with ECS and nonmatted nodes. Bivariate testing showed that matted nodes were predictive of survival within the AJCC nodal classification system. There were 79 patients who presented with AJCC N2b disease. Of these 79 patients, 16 patients had matted nodes and 63 had no evidence of matted nodes. There was a significant difference in the DSS in patients with N2b disease when stratifying by matted nodes ( Figure  6A ; p 5 .0001). There were 51 patients who presented with AJCC N2c disease. Of these 51 patients, 12 patients had matted nodes and 39 had no evidence of matted nodes. There was a significant difference in the DSS in patients with N2c disease when stratifying by matted nodes ( Figure 6B ; p 5 .0001). There were 29 patients who presented with AJCC N3 disease. Of these 29 patients, 14 patients had matted nodes and 15 had no evidence of matted nodes. There was a significant difference in the DSS in patients with N3 disease when stratifying by matted nodes (Figure 6C ; p 5 .009). Matted nodes independently predicted survival within each AJCC nodal classification.
A bivariate analysis of the prognostic value of matted nodes was evaluated within the following variables: HPV status, tobacco use, and T classification. Matted nodes were a poor prognostic factor of DSS in HPV-positive patients (p 5 .0001) but not in HPV-negative patients (p 5 .14). The HPV-negative group contained 15 patients and was underpowered. Matted nodes were a poor prognostic factor among never (p 5 .0001), ever (p 5 .0001), and current (p 5 .0001) tobacco users. In addition, matted FIGURE 2. Kaplan-Meier survival curves of the entire cohort stratified by the presence of matted nodes. The 3-year diseasespecific survival (DSS) for patients with matted nodes was 58% and for patients with no evidence of matted nodes was 97% (p 5 .0001). [Color figure can be viewed in the online issue, which is available at wileyonlinelibrary.com.] FIGURE 3. Kaplan-Meier survival curves of the entire cohort stratified by human papillomavirus (HPV) status. The 3-year disease-specific survival (DSS) for HPV-positive patients was 88% and for HPV-negative patients was 69% (p 5 .05). [Color figure can be viewed in the online issue, which is available at wileyonlinelibrary.com.] FIGURE 4. Kaplan-Meier survival curves of the entire cohort stratified by smoking status. The 3-year disease-specific survival (DSS) was 90%, 85%, and 88% in the never, prior, and current tobacco use groups, respectively. There were no significant differences between the groups. [Color figure can be viewed in the online issue, which is available at wileyonlinelibrary.com.] nodes were a poor prognostic factor in patients with low T classification (T1/T2; p 5 .0001) and high T classification (T3/T4; p 5 .0001).
Multivariate analysis was performed using matted nodes, age, T classification, HPV status, and smoking status, and is shown in Table 3 . Matted nodes were an independent predictor of poor prognosis when controlling for these variables (DSS hazard ratio 5 14.1; 95% confidence interval 5 6.0-33.1; p < .0001)
DISCUSSION
This study shows that matted nodes are an important independent predictor of distant metastasis and survival in patients with oropharyngeal SCC. The predictive ability of matted nodes facilitates the identification of patients who might benefit from novel treatment interventions to prevent the development or progression of distant metastasis. The absence of matted nodes also helps identify patients who are at lower risk for distant treatment failure.
Matted nodes are not a surrogate marker for extensive neck disease or an alternative description of massive neck involvement for nodal metastasis. The analysis presented in this article shows that matted nodes are present in patients with N2b, N2c, and N3 disease, and within these AJCC classifications are associated with higher rates of distant metastasis ( Figure 6 ). Previous work has stratified patients with nodal metastasis into risk groups. 7 found that patients treated with chemoradiation who had T4 or N3 disease had higher rates of distant disease. We believe that the characteristics associated with matted nodes may extend these findings and will be a more specific marker for distant metastasis. It is particularly important to note that the imaging characteristics that reflect the biology of metastases to multiple regional lymph nodes are independent of overall tumor stage, smoking history, and perhaps even HPV status. Better understanding of the molecular characteristics associated with the imaging finding of matted nodes versus nonmatted nodes is likely to reveal factors directly associated with metastatic behavior and potentially new targets for therapy of disseminated disease.
There were several potential weaknesses in this study. The predictive value of matted nodes needs to be validated in more than 1 institution and in more than 1 protocol. In addition, the analysis is "post hoc" and to be sure of the predictive value of matted nodes it would have to be tested in a prospective study. Also, our treatment protocol is not the most commonly used regimen of concurrent chemotherapy and radiation. Patients were treated with carboplatin and paclitaxel, which could be inferior to high-dose cisplatin in patients with oropharyngeal SCC. Having stated this, the OS and DSS in our cohort compares favorably to high-dose cisplatinum regimens. 13 Combined treatment of oropharyngeal SCC has effectively improved control of local and regional disease. 2, 7, 9 The subset of patients who develop distant metastatic disease do so without a clear biologic marker. Matted nodes are a clinically useful predictor of distant metastasis in oropharyngeal SCC that is associated with poor survival. For patients who are at risk for developing distant disease, matted nodes seem to be a useful clinical predictor of this aggressive phenotype. We lack pathological information about matted nodes because it is a radiologic finding and no pathologic correlate was available because all patients were managed nonsurgically. Whether matted nodes represent extensive ECS or an immunologic response is unknown, but our findings certainly suggest that matted nodes represent a marker of a biologically different disease. The positive predictive value of developing distant metastasis when matted nodes are present was 66%, and the negative predictive value was 99%. The sensitivity and specificity of matted nodes to predict distant metastasis was 93% and 92%, respectively. The predictive ability of matted nodes facilitates the identification of patients who may benefit from novel treatment interventions to prevent the development or progression of distant metastasis. 
